Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusion.

The fusion peptides of HIV and influenza virus are crucial for viral entry into a host cell. We report the membrane-perturbing and structural properties of fusion peptides from the HA fusion protein of influenza virus and the gp41 fusion protein of HIV. Our goals were to determine: 1), how fusion peptides alter structure within the bilayers of fusogenic and nonfusogenic lipid vesicles and 2), how fusion peptide structure is related to the ability to promote fusion. Fluorescent probes revealed that neither peptide had a significant effect on bilayer packing at the water-membrane interface, but both increased acyl chain order in both fusogenic and nonfusogenic vesicles. Both also reduced free volume within the bilayer as indicated by partitioning of a lipophilic fluorophore into membranes. These membrane ordering effects were smaller for the gp41 peptide than for the HA peptide at low peptide/lipid ratio, suggesting that the two peptides assume different structures on membranes. The influenza peptide was predominantly helical, and the gp41 peptide was predominantly antiparallel beta-sheet when membrane bound, however, the depths of penetration of Trps of both peptides into neutral membranes were similar and independent of membrane composition. We previously demonstrated: 1), the abilities of both peptides to promote fusion but not initial intermediate formation during PEG-mediated fusion and 2), the ability of hexadecane to compete with this effect of the fusion peptides. Taken together, our current and past results suggest a hypothesis for a common mechanism by which these two viral fusion peptides promote fusion.

[1]  A. Waring,et al.  The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation. , 1992, Biochimica et biophysica acta.

[2]  E. Freed,et al.  Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S H White,et al.  Folding of beta-sheet membrane proteins: a hydrophobic hexapeptide model. , 1998, Journal of molecular biology.

[4]  J. Knutson,et al.  Interaction of influenza hemagglutinin amino-terminal peptide with phospholipid vesicles: a fluorescence study. , 1991, Biochemistry.

[5]  D. Wilkinson HIV-1: Cofactors provide the entry keys , 1996, Current Biology.

[6]  D. Dimitrov,et al.  Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes. , 1991, AIDS research and human retroviruses.

[7]  M. Kozlov,et al.  Delay of influenza hemagglutinin refolding into a fusion-competent conformation by receptor binding: a hypothesis. , 2000, Biophysical journal.

[8]  P. Axelsen,et al.  Membrane-induced folding of cecropin A. , 2000, Biophysical journal.

[9]  B. Lentz,et al.  Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. , 1993, Chemistry and physics of lipids.

[10]  J. White,et al.  Viral and cellular membrane fusion proteins. , 1990, Annual review of physiology.

[11]  Lukas K. Tamm,et al.  Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin , 2001, Nature Structural Biology.

[12]  C. Gray,et al.  Effect of the N-terminal glycine on the secondary structure, orientation, and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers. , 1996, Biophysical journal.

[13]  B. Lentz,et al.  Outer leaflet-packing defects promote poly(ethylene glycol)-mediated fusion of large unilamellar vesicles. , 1997, Biochemistry.

[14]  J. Skehel,et al.  Membrane fusion by peptide analogues of influenza virus haemagglutinin. , 1988, The Journal of general virology.

[15]  F. Goñi,et al.  Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage. , 1994, Biochemistry.

[16]  W. DeGrado,et al.  Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. , 1990, Biochemistry.

[17]  S. Takahashi Conformation of membrane fusion-active 20-residue peptides with or without lipid bilayers. Implication of alpha-helix formation for membrane fusion. , 1990, Biochemistry.

[18]  F. Goñi,et al.  Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects. , 1997, Biophysical journal.

[19]  D. Hoekstra,et al.  Peptides and Membrane Fusion: Towards an Understanding of the Molecular Mechanism of Protein-Induced Fusion , 1999, The Journal of Membrane Biology.

[20]  W. DeGrado,et al.  Membrane fusion activity of the influenza virus hemagglutinin: interaction of HA2 N-terminal peptides with phospholipid vesicles. , 1991, Biochemistry.

[21]  F. Hughson Structural characterization of viral fusion proteins , 1995, Current Biology.

[22]  S. Takahashi,et al.  Orientation of fusion-active synthetic peptides in phospholipid bilayers: determination by Fourier transform infrared spectroscopy. , 1993, Biochemistry.

[23]  B. Lentz,et al.  Binding of bovine factor Va to phosphatidylcholine membranes. , 1996, Biophysical journal.

[24]  D. Craik,et al.  The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids , 1999, European Biophysics Journal.

[25]  D. Engelman,et al.  Lipid bilayer thickness varies linearly with acyl chain length in fluid phosphatidylcholine vesicles. , 1983, Journal of molecular biology.

[26]  J. Ruysschaert,et al.  Structure and Topology of the Influenza Virus Fusion Peptide in Lipid Bilayers (*) , 1995, The Journal of Biological Chemistry.

[27]  D. Alford,et al.  Spontaneous fusion of phosphatidylcholine small unilamellar vesicles in the fluid phase. , 1987, Biochemistry.

[28]  S. Slater,et al.  Fluorescence techniques for probing water penetration into lipid bilayers , 1995, Journal of Fluorescence.

[29]  N. Werthessen,et al.  Studies on the biosynthesis of cholesterol. III. Purification of C14-cholesterol from perfusions of livers and other organs. , 1952, Archives of biochemistry and biophysics.

[30]  M. Tsurudome,et al.  Lipid interactions of the hemagglutinin HA2 NH2-terminal segment during influenza virus-induced membrane fusion. , 1992, The Journal of biological chemistry.

[31]  R. Epand,et al.  Relationship between the infectivity of influenza virus and the ability of its fusion peptide to perturb bilayers. , 1994, Biochemical and biophysical research communications.

[32]  Y. Shai,et al.  Fusion Peptides Derived from the HIV Type 1 Glycoprotein 41 Associate within Phospholipid Membranes and Inhibit Cell-Cell Fusion , 1997, The Journal of Biological Chemistry.

[33]  T. McIntosh,et al.  Determination of the depth of bromine atoms in bilayers formed from bromolipid probes. , 1987, Biochemistry.

[34]  P. Axelsen,et al.  Infrared spectroscopy of supported lipid monolayer, bilayer, and multibilayer membranes. , 1998, Chemistry and physics of lipids.

[35]  P. S. Chen,et al.  Microdetermination of Phosphorus , 1956 .

[36]  J. Ruysschaert,et al.  Protein-induced Fusion Can Be Modulated by Target Membrane Lipids through a Structural Switch at the Level of the Fusion Peptide* , 2000, The Journal of Biological Chemistry.

[37]  S. Zhao,et al.  Cell-surface exposure of phosphatidylserine correlates with the stage of fludarabine-induced apoptosis in chronic lymphocytic leukemia and expression of apoptosis-regulating genes. , 2000, Cytometry.

[38]  P. Axelsen,et al.  The Structure of Human Lipoprotein A-I , 1999, The Journal of Biological Chemistry.

[39]  F. Richards,et al.  The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. , 1991, The Journal of biological chemistry.

[40]  S. Durell,et al.  What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review). , 1997, Molecular membrane biology.

[41]  T. Matsumoto Membrane destabilizing activity of influenza virus hemagglutinin-based synthetic peptide: implications of critical glycine residue in fusion peptide. , 1999, Biophysical chemistry.

[42]  Howard L. Brockman,et al.  Use of Internal Reflectance Infrared Spectroscopy for the in Situ Study of Supported Lipid Monolayers , 1995 .

[43]  C. M. Gabrys,et al.  Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide. , 2001, Biochemistry.

[44]  Structural study of the interaction between the SIV fusion peptide and model membranes. , 1996 .

[45]  M. Gething,et al.  Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus , 1986, The Journal of cell biology.

[46]  B. Lentz,et al.  Effects of hemagglutinin fusion peptide on poly(ethylene glycol)-mediated fusion of phosphatidylcholine vesicles. , 2001, Biochemistry.

[47]  G. Nakamura,et al.  Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.

[48]  B. Lentz,et al.  Energetics of vesicle fusion intermediates: comparison of calculations with observed effects of osmotic and curvature stresses. , 2004, Biophysical journal.

[49]  J. Bandekar,et al.  Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. , 1986, Advances in protein chemistry.

[50]  Franca Fraternali,et al.  Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers. , 2005, Biophysical journal.

[51]  J. Bentz Viral Fusion Mechanisms , 1993 .

[52]  D. Weliky,et al.  Solid-state nuclear magnetic resonance evidence for parallel and antiparallel strand arrangements in the membrane-associated HIV-1 fusion peptide. , 2003, Biochemistry.

[53]  J. Ruysschaert,et al.  Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer , 1996, Journal of virology.

[54]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[55]  R. Brasseur,et al.  Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes. , 1993, Biochimica et biophysica acta.

[56]  A. Mandinova,et al.  Dynamics of membrane translocation of phosphatidylserine during apoptosis detected by a monoclonal antibody , 2005, Apoptosis.

[57]  M. Haque,et al.  Influence of gp41 fusion peptide on the kinetics of poly(ethylene glycol)-mediated model membrane fusion. , 2002, Biochemistry.

[58]  S. Takahashi,et al.  pH-dependent membrane fusion activity of a synthetic twenty amino acid peptide with the same sequence as that of the hydrophobic segment of influenza virus hemagglutinin. , 1987, Journal of biochemistry.

[59]  P. Axelsen,et al.  Fourier transform infrared linked analysis of conformational changes in annexin V upon membrane binding. , 1999, Biochemistry.

[60]  S. Takahashi,et al.  pH-dependent membrane fusion and vesiculation of phospholipid large unilamellar vesicles induced by amphiphilic anionic and cationic peptides. , 1992, Biochemistry.

[61]  M. Bally,et al.  Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. , 1985, Biochimica et biophysica acta.

[62]  D. Zhelev,et al.  Interaction of synthetic HA2 influenza fusion peptide analog with model membranes. , 2001, Biophysical journal.

[63]  V. Slepushkin,et al.  Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function. , 1992, AIDS research and human retroviruses.

[64]  M. B. Kelly,et al.  The modulation of protein kinase C activity by membrane lipid bilayer structure. , 1994, The Journal of biological chemistry.

[65]  R. Rand,et al.  Comparative study of the effects of several n-alkanes on phospholipid hexagonal phases. , 1998, Biophysical journal.

[66]  P. Frederik,et al.  Osmotic and curvature stress affect PEG-induced fusion of lipid vesicles but not mixing of their lipids. , 2002, Biophysical journal.

[67]  A. Verkleij,et al.  The interaction of synthetic analogs of the N-terminal fusion sequence of influenza virus with a lipid monolayer. Comparison of fusion-active and fusion-defective analogs. , 1991, Biochimica et biophysica acta.

[68]  P. Axelsen,et al.  Orientational order determination by internal reflection infrared spectroscopy. , 1996, Progress in biophysics and molecular biology.

[69]  E. London,et al.  Parallax method for direct measurement of membrane penetration depth utilizing fluorescence quenching by spin-labeled phospholipids. , 1987, Biochemistry.

[70]  D. Parks,et al.  Bilayer curvature and certain amphipaths promote poly(ethylene glycol)-induced fusion of dipalmitoylphosphatidylcholine unilamellar vesicles. , 1992, Biochemistry.

[71]  W. DeGrado,et al.  Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. , 1987, The Journal of biological chemistry.

[72]  C. Broder,et al.  HIV and the 7-transmembrane domain receptors. , 1996, Pathobiology : journal of immunopathology, molecular and cellular biology.

[73]  C. M. Gabrys,et al.  Temperature dependence and resonance assignment of 13C NMR spectra of selectively and uniformly labeled fusion peptides associated with membranes , 2004, Magnetic resonance in chemistry : MRC.

[74]  W. Chien,et al.  The amino-terminal fusion domain peptide of human immunodeficiency virus type 1 gp41 inserts into the sodium dodecyl sulfate micelle primarily as a helix with a conserved glycine at the micelle-water interface , 1997, Journal of virology.

[75]  N. Sreerama,et al.  Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. , 2000, Analytical biochemistry.

[76]  G. Melikyan,et al.  Tension of membranes expressing the hemagglutinin of influenza virus inhibits fusion. , 1999, Biophysical journal.